Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a special type of breast cancer in which ER, PR and HER2 are all negative, characterized by high malignancy, strong invasiveness, and high recurrence rate. It is critical to develop novel drugs for improved therapies for triple-negative breast cancers. Here, w...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
KeAi Communications Co., Ltd.,
2023-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|